Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma - Wikidata - awgldk - TriplyDB

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

http://www.wikidata.org/entity/Q34593395

about

Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies A summary of the osteosarcoma banking efforts: a report from the Children's Oncology Group and the QuadW Foundation BIMMER: a novel algorithm for detecting differential DNA methylation regions from MBDCap-seq data.Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy.The role of the human psoralen 4 (hPso4) protein complex in replication stress and homologous recombination.Digital expression profiling identifies RUNX2, CDC5L, MDM2, RECQL4, and CDK4 as potential predictive biomarkers for neo-adjuvant chemotherapy response in paediatric osteosarcoma.Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma.Detection of kinase amplifications in gastric cancer archives using fluorescence in situ hybridization.Ladder-like amplification of the type I interferon gene cluster in the human osteosarcoma cell line MG63 Combinatorial treatment of DNA and chromatin-modifying drugs cause cell death in human and canine osteosarcoma cell lines.The Role of RUNX2 in Osteosarcoma Oncogenesis.Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.The genetics of osteosarcoma.Clinical and biological significance of PIM1 kinase in osteosarcoma.Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma Phosphoproteomic analysis of the highly-metastatic hepatocellular carcinoma cell line, MHCC97-H Whole exome sequencing of a single osteosarcoma case--integrative analysis with whole transcriptome RNA-seq data.The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models.Multiple cis-elements and trans-acting factors regulate dynamic spatio-temporal transcription of let-7 in Caenorhabditis elegans A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis.The cancer-related transcription factor Runx2 modulates cell proliferation in human osteosarcoma cell lines The molecular landscape of extraskeletal osteosarcoma: A clinicopathological and molecular biomarker study.Depletion of pre-mRNA splicing factor Cdc5L inhibits mitotic progression and triggers mitotic catastrophe Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.RETRACTED: Establishing an osteosarcoma associated protein-protein interaction network to explore the pathogenesis of osteosarcoma.Integrated genomic and functional analyses reveal glyoxalase I as a novel metabolic oncogene in human gastric cancer.Biological characterization of preclinical Bioluminescent Osteosarcoma Orthotopic Mouse (BOOM) model: A multi-modality approach.Integrative analysis reveals relationships of genetic and epigenetic alterations in osteosarcoma Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells.Expression of CDC5L is associated with tumor progression in gliomas.Coamplification of Myc/Pvt1 and homozygous deletion of Nlrp1 locus are frequent genetics changes in mouse osteosarcoma.Expression of Human MDGA1 Increases Cell Motility and Cell-Cell Adhesion and Reduces Adhesion to Extracellular Matrix Proteins in MDCK Cells Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.Hedgehog signaling induces osteosarcoma development through Yap1 and H19 overexpression.Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling.Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.Evaluation of gene expression level of CDC5L and MACC1 in poor prognosis and progression of osteosarcoma

P2860

Q26782646-C87B2224-08FD-4103-BB2F-ECEA870C361A Q28386370-8BBCE63C-64BA-44E2-B9DA-B8087A4E1777 Q30874301-D954FD1C-57DC-45F7-BD5D-813064DE826F Q33577472-125418F8-34E8-4779-A50D-768958880394 Q33619419-1138E907-E06A-4E22-8E10-C90D189EE26F Q33623477-9CBBB87C-126A-48E1-B7E3-BF4BC92BD1F6 Q34146537-6C1FE806-58F8-469D-887F-B3A8A1A95812 Q34228576-4A20C1BE-2163-487B-A9AC-7B27C6A195FC Q34301120-66E42DE5-3161-4A4D-A07C-FF96D42CDC2B Q34344422-EBD75C8E-7463-4EB8-8B70-3F445FDC8FBB Q34407959-EC4EE559-B2A8-41E2-8596-9385AC503A75 Q34423871-9F194C56-69BB-40A8-A216-E43A5A3D9A46 Q34570006-0C51D5A2-ADCB-48EF-9E03-75C8C1A7BDE1 Q34639086-7112B532-7CDC-4CF7-B80A-C4B3E975EE8D Q34674917-B7570365-1559-4C8F-802B-DF7200ACD876 Q35065555-E31032B3-1D3C-4AE5-80C8-E18CBCEFE021 Q35139225-EA26A1A1-ABBD-4CC6-8DD1-5BD3AA1C093D Q35511058-5B048A3C-6EB0-4F30-B085-12CB2103E427 Q36309953-191FF0EF-7A02-4125-91B3-BCFD6B06443B Q36545027-A20A9CAF-06FA-449F-9C92-3B41304AD96C Q36617953-4CC19132-80DA-40E1-B6F6-9A5569BDC28F Q36672392-7CD9DBCB-3823-4861-808B-D1ABDD7E1C9A Q36873828-C3E42FEB-5C94-40B2-8AC5-93C0647C83C7 Q37680180-DA5F2531-8B1A-455A-A9A9-D1547714EB2C Q37897986-D4217E63-AF31-44F2-A763-1550320B840C Q38482145-1F8C4FC0-692F-42E5-8544-29FE15D18662 Q39012316-66BFF06D-39FE-48F3-81C3-73F7F62DC2A3 Q39202192-38C383A1-C508-4589-9915-6EC7B5C18A05 Q39246205-74D9ED3B-29D4-4807-A1B3-57B7064154D8 Q39801788-5894C11B-E5D1-4693-AF9C-1EF7B44C95A2 Q41194997-8321F238-5640-4532-8907-0F02A41F551B Q41380246-4050CCA7-066E-44F7-BE29-008B0D7C2A91 Q42646135-3930E0F3-893D-4938-A602-66C0F81940A5 Q44861620-E4BA819C-38D9-4463-9DE0-4448142C1138 Q46525173-5F0CA65C-03B0-4D7F-A60F-26EFD610659E Q47330690-DE8D3841-ED22-4D0A-A7CD-196F6487A065 Q52592465-B0309DD1-6CD5-4F32-B456-F891A33ACBF4 Q54117592-A285D9F3-F526-46BA-BCEB-5A80537857A5 Q56486862-0934F1C6-42BE-4343-9ECC-39CAB8EA4C32

P2860

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

http://www.wikidata.org/entity/Q34593395

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

@ast

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

@en

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

@nl

type

label

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

@ast

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

@en

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

@nl

prefLabel

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

@ast

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

@en

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

@nl

P1433

Q34593395-A29F7A7E-C861-4529-8316-CB4EEE52EFE8

P1476

Q34593395-900E5F37-C8C9-44C0-880C-E58232D59AB7

P2093

Q34593395-181161D0-E8DC-4C68-AE31-58929B6FAC94

Q34593395-1996204D-934A-4568-9A9A-0BC509674D7F

Q34593395-272E8CE9-DD54-40DD-953A-A0783D689210

Q34593395-3AEC1E4B-346C-480A-A580-B9821A1B4E23

Q34593395-4F624A19-147E-4F45-B66F-BBACEB4519DC

Q34593395-506870FD-EA33-4F7E-9B4F-621EFC51EA8D

Q34593395-5CE3F32D-1709-40B0-985A-8AE06E294796

Q34593395-6C71DBB3-CB53-4359-8C20-052B5EDE8037

Q34593395-811330B0-EA91-48CF-AE45-CF53482CB890

Q34593395-88566529-D630-4F3C-B407-40AFD2897F56

P2860

Q34593395-06EB2812-0C11-45AF-86DB-E5BEE40231E3

Q34593395-1EAAA5F9-DA25-4A0B-AF48-5088BB6D8514

Q34593395-2AF82B7D-DDB7-457F-B394-EC89D33CD4A5

Q34593395-2F311745-583E-4EA4-96E1-222B7BDF3DE1

Q34593395-2F8B6FAF-6ECC-47DC-AD9F-BBF58AD8AE0F

Q34593395-3A9AC2DE-4639-49DB-943A-213DEF154DCF

Q34593395-424FBFE5-9DF0-4CFD-B6DE-EE3A5473E5DE

Q34593395-42DDEC7F-C721-4B33-BB5E-A98891395C3B

Q34593395-5A92218A-ECAC-476C-9ADF-EEA39D58AD4F

Q34593395-5AAA3EFE-4C6A-41D7-8FDB-2EC9524C00B2

P304

Q34593395-85E50E1F-A2C6-42F4-94B1-55F140D6469F

P31

Q34593395-130AC80C-545F-4702-BA80-5F220F2E3E3B

P356

Q34593395-33A63E3C-3150-48D4-A296-64BA6485CCA7

P433

Q34593395-9F2EAF9D-C7C3-44EE-BF04-11D0B23A48AC

P478

Q34593395-465D4F83-1393-4DFD-BB96-2A862EE86B9F

P50

Q34593395-6BD4CB25-49C4-46D5-A73D-99ECBAC927F2

Q34593395-7BDBFFA9-0DE6-4456-B6A2-7CE168FD101B

P577

Q34593395-4CCB7A95-68D2-4446-A3E1-334DE4744AAA

P5875

Q34593395-D8A9D1A0-E9B3-4AC0-888E-B4D94006B782

P698

Q34593395-07112436-C346-482A-9FD1-B5759C9420F9

P932

Q34593395-7945E932-2699-45CC-98B2-05FD41AB8A46

P356

1541-7786.MCR-07-2115

P1433

Molecular Cancer Research

P1476

Cell cycle regulator gene CDC5L, a potential target for 6p12-p21 amplicon in osteosarcoma

@en

P2093

Ching C Lau

http://www.w3.org/2001/XMLSchema#string

Debananda Pati

http://www.w3.org/2001/XMLSchema#string

Gouqing Ge

http://www.w3.org/2001/XMLSchema#string

Jason Kang

http://www.w3.org/2001/XMLSchema#string

John Hicks

http://www.w3.org/2001/XMLSchema#string

Kim Jaeweon

http://www.w3.org/2001/XMLSchema#string

Laszlo Perlaky

http://www.w3.org/2001/XMLSchema#string

Li Xiao-Nan

http://www.w3.org/2001/XMLSchema#string

Michael Sheldon

http://www.w3.org/2001/XMLSchema#string

Murali Chintagumpala

http://www.w3.org/2001/XMLSchema#string

P2860

The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification

Linking sister chromatid cohesion and apoptosis: role of Rad21.

Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma

The RUNX genes: gain or loss of function in cancer

A mammalian homolog of fission yeast Cdc5 regulates G2 progression and mitotic entry

Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas

Chromosomal regions involved in the pathogenesis of osteosarcomas.

Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma

The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability.

Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma

P304

937-946

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1541-7786.MCR-07-2115

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Murali Chintagumpala

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5288387

http://www.w3.org/2001/XMLSchema#string

P698

18567798

http://www.w3.org/2001/XMLSchema#string

P932

2693718

http://www.w3.org/2001/XMLSchema#string